Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer.
10.3802/jgo.2013.24.3.209
- Author:
Eric PUJADE-LAURAINE
1
Author Information
1. Unite Cancer de la Femme et Recherche Clinique, Hopitaux Universitaires Paris Centre, site Hotel-Dieu, Universite Paris Descartes, Paris, France. epujade@arcagy.org
- Publication Type:Editorial
- MeSH:
Antibodies, Monoclonal, Humanized;
Bevacizumab;
Cyclophosphamide;
Ovarian Neoplasms
- From:Journal of Gynecologic Oncology
2013;24(3):209-211
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
